Emami Limited (NSE:EMAMILTD)
India
· Delayed Price · Currency is INR | Market Cap | 198.26B |
| Revenue (ttm) | 38.17B |
| Net Income (ttm) | 7.94B |
| Shares Out | n/a |
| EPS (ttm) | 18.20 |
| PE Ratio | 24.96 |
| Forward PE | 22.47 |
| Dividend | 12.00 (2.63%) |
| Ex-Dividend Date | Feb 10, 2026 |
| Volume | 290,105 |
| Average Volume | 643,700 |
| Open | 460.80 |
| Previous Close | 461.60 |
| Day's Range | 452.55 - 461.75 |
| 52-Week Range | 385.50 - 653.35 |
| Beta | 0.12 |
| RSI | 62.84 |
| Earnings Date | May 21, 2026 |
About Emami
Emami Limited manufactures and markets personal and healthcare products in India and internationally. The company offers antiseptic cream, body lotion, prickly heat powder, petroleum jelly, soaps, aloe vera gel, and all-season cream under the BoroPlus brand; oil and cool talc products under the Navratna brand; and ayurvedic products for pain management, immunity, digestive health, and bone and joint health, as well as healthcare products comprising hair growth vitalizers, skin elixirs, organic apple cider vinegar, cough syrup, herbal tea, healt... [Read more]
Financial Performance
In fiscal year 2025, Emami's revenue was 38.09 billion, an increase of 6.46% compared to the previous year's 35.78 billion. Earnings were 8.06 billion, an increase of 11.46%.
Financial StatementsNews
Emami acquires 73.5% stake in Axiom Ayurveda for Rs 200 crore
Emami Limited has announced its decision to acquire a 73.5% stake in Axiom Ayurveda Private Limited, an associate company, for a total consideration of up to ₹200 crore. This acquisition…
Emami Ltd (BOM:531162) Q3 2026 Earnings Call Highlights: Strong Sales Growth and Strategic ...
Emami Ltd (BOM:531162) Q3 2026 Earnings Call Highlights: Strong Sales Growth and Strategic Expansion Amid Challenges
Q3 2026 Emami Ltd Earnings Call Transcript
Q3 2026 Emami Ltd Earnings Call Transcript
Emami Transcript: Q3 25/26
Q3 FY26 saw 11% sales growth and 15% PAT growth, with strong performance across major brands and digital channels. Gross margin and EBITDA margin improved, and rural demand showed double-digit growth. GST cuts and supply chain initiatives are expected to drive further gains.
Emami Ltd (BOM:531162) Q2 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth
Emami Ltd (BOM:531162) Q2 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth
Q2 2026 Emami Ltd Earnings Call Transcript
Q2 2026 Emami Ltd Earnings Call Transcript
Emami Transcript: Q2 25/26
Q2 FY26 saw a 10% revenue decline due to GST-driven trade disruptions and weak summer sales, but non-GST portfolios and international business grew. Management expects a strong H2 rebound, with winter loading recovered and GST benefits supporting future growth.
Emami Q2 FY26 results: Profit falls 30% YoY to ₹148 crore, revenue down 10%
Emami Limited announced its consolidated results for the second quarter of FY26, reporting a decline across key financial metrics compared...
Emami Transcript: Q1 25/26
Revenue was flat due to weak summer demand, but core domestic business grew 6% excluding talc. Gross margin rose to 69.4%, with PAT up 9% and pain management, BoroPlus, and digital channels driving growth. Margin outlook remains positive.
Emami Q1 Results: Revenue flat at Rs 905 crore, Net Profit up 9% YoY
Emami Ltd. reported its financial results for the quarter ended June 30, 2025 (Q1 FY26), with modest top-line growth and steady profit expansion despite a challenging cost environment. Key Highlights ...
Nuvama on Emami share price: Buy retained, target cut to Rs 895 on FY26/27 EPS forecasts
Nuvama has maintained its buy rating on Emami Ltd, while revising its target price downward to ₹895 from ₹925. This implies a potential upside of approximately 41% from the current market price of ₹63...
Emami net profit rises 9% to Rs 162cr in Q4 FY25
Kolkata: FMCG major Emami Ltd registered a 9% jump in consolidated net profit to Rs 162 crore in Q4 of 2024-25 from Rs 146 crore in the year-ago perio.
Emami Transcript: Q4 24/25
Q4 FY25 saw 8% revenue growth and margin expansion, with strong domestic and international rebounds. Strategic investments in male grooming, D2C, and healthcare, plus new leadership and product launches, position the business for robust FY26 growth.
Emami Q4 results: Revenue jumps 8.1%YoY to Rs 963 crore, net profit up 8.7% YoY
Emami Limited reported its financial results for the fourth quarter, showing moderate year-on-year growth in both profit and revenue. The company’s net profit rose by 8.7% to ₹162 crore, compared to ₹...
Emami Transcript: Q3 24/25
Core domestic business grew 8.6% in Q3 FY25, with strong gains in BoroPlus and healthcare segments, while gross margin expanded to 70.3%. Despite challenges in male grooming and international markets, profit and EBITDA rose 8%, and the company reaffirmed its robust dividend payout.
Emami shares surge over 3% followinf Q3 FY25 results
Emami Ltd, the homegrown FMCG major, posted a strong performance in Q3 FY25, with a 7.03% year-on-year (YoY) increase in net profit at ₹278.98 crore, compared to ₹260.65 crore in the corresponding qua...
Emami Q3 FY25: Revenue rises 5.3% YoY to Rs 1,049 crore, profit jumps 32% to Rs 279 crore
Emami Limited reported its financial performance for Q3 FY25, showing a 5.3% year-on-year (YoY) increase in revenue from operations, which stood at ₹1,049 crore compared to ₹996 crore in Q3 FY24. The ...
Emami eyes Rs 1k cr revenue, rebrands male grooming range
Kolkata: After rebranding Fair And Handsome to Smart And Handsome on Thursday, Emami Ltd is eyeing Rs 1,000 crore revenue from the male grooming brand.
Emami Fined Rs 15 Lakh For "Misleading, Unfair" Claims Over Fairness Cream
A district consumer forum imposed a fine of Rs 15 lakh on Emami Ltd for unfair trade practices after a man alleged that the company's fairness cream advertisement was deceptive and misleading.
Fair is foul? Consumer panel tells cosmetic brand to pay up for misleading claim on package
A Delhi consumer panel has ruled against Emami Limited for misleading claims on its Fair and Handsome cream, ordering the company to pay Rs 15 lakh in damages for unfair trade practices. The ruling em...
Emami Transcript: Q2 24/25
Q2 FY25 saw 3% revenue growth and 7% EBITDA growth, with margin expansion despite inflation and geopolitical headwinds. Key brands like Navratna and Dermicool grew double digits, while Kesh King and male grooming declined. Management remains optimistic for H2, targeting high single-digit revenue and double-digit EBITDA growth.
Emami Q2 FY25 Results: Revenue increases 3% YoY to ₹891 crore, PAT rises by 19.1%
Emami Limited has reported its financial results for the second quarter of FY25, showing a solid increase in revenue and profitability year-over-year (YoY), driven by improved operational performance ...
How are these stocks reacting ahead of Q2 results – RVNL, NHPC, Trent, Lupin and more
Ahead of their Q2 FY24-25 results announcement, several companies are witnessing notable movements in their stock prices as of 9:24 AM: RVNL: ₹480.00 (+2.20%) – Positive sentiment with a 2.20% increas...
Bangladesh ops slowly stabilising, says Emami
Kolkata: The Bangladesh operations of Emami Ltd were gradually stabilising and, like Sri Lanka, the FMCG major did not foresee any big impact, CFO N B.
Emami Transcript: Q1 24/25
Q1 FY25 saw 10% revenue growth, strong summer portfolio performance, and improved margins, with rural demand recovering and digital channels expanding. Strategic initiatives are underway for underperforming segments, and cautious optimism is maintained for the year ahead.